Patent · US Active

Nicotine containing formulation

US9180124B2 · kind B2 · utility

0Cited by

10References

8Claims

0Family size

Assignee

J. B. Chemicals and Pharmaceuticals Limited · IN

Inventors

Bharat Pravinchandra Mehta · Mumbai, IN
Rajen Shah · Pune, IN
Manoj Patel · Berlin, US
Parmeshwar B. Bang · Vapi, IN

Key dates

Filing date	Dec 1, 2010
Grant date	Nov 10, 2015
Priority date	—
Expiry date	Dec 1, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is nicotine containing solid oral transmucosal dosage forms containing a therapeutically effective amount of nicotine polacrilex, citric acid monohydrate, sucrose and liquid glucose. The dosage form is preferably in the form of lozenge.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.